ClinicalTrials.Veeva

Menu

Non-invasive Secondary Respiratory Support in Late Preterm and Term Infants

A

Alexandria University

Status

Completed

Conditions

Neonates
Non- Invasive Ventilation
Respiratory Distress

Treatments

Device: NCPAP
Device: NIPPV
Device: NHFOV

Study type

Interventional

Funder types

Other

Identifiers

NCT07000071
0201275

Details and patient eligibility

About

The aim of the present work is to compare between various modes of non-invasive respiratory support (including NCPAP, NIPPV, and NHFOV) as secondary respiratory support modes in late preterm and term neonates as regards the need for reintubation. Additionally, the study aims at comparing between the three modes concerning the associated morbidity and mortality.

Enrollment

40 patients

Sex

All

Ages

1 to 14 days old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The gestational age (GA) is between 34 and 41 weeks.
  • Extubation from invasive mechanical ventilation initiated due to RD, irrespective to the cause of RD.
  • Respiratory distress is assessed based on clinical manifestations (tachypnea, nasal flaring, intercostal retractions, diminished air entry, and or grunting)

Exclusion criteria

  • Major congenital anomalies.
  • Major cardiac diseases.
  • Presence of cardiovascular instability (sepsis, severe dehydration, severe anemia).
  • Neurologically insulted neonates who are unable to take adequate spontaneous breathing.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 3 patient groups

Nasal Continuous positive airway pressure (NCPAP)
Active Comparator group
Description:
apply continuous positive airway pressure using nasopharyngeal interface. positive end expiratory pressure (PEEP ) used 5-7 cm H2O. Neonates will be supported with NCPAP following extubation.
Treatment:
Device: NCPAP
Nasal intermittent pressure ventilation (NIPPV)
Active Comparator group
Description:
Neonates will be supported with NIPPV following extubation.
Treatment:
Device: NIPPV
Nasal high frequency ventilation (NHFOV)
Active Comparator group
Description:
Neonates will be supported with NHFOV following extubation. stating mean airway pressure 8 and can reach upto 15 cm H2O Delta pressure used is 20 Frequency 10 HZ
Treatment:
Device: NHFOV

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems